Aclaris Therapeutics
Matthew Rothman has served as General Counsel and Corporate Secretary since November 2022. He joined Aclaris in 2018 and has served in a number of roles of increasing responsibility within the legal department. Prior to joining Aclaris, Matt was an associate in the corporate and securities group at the global law firm Dechert LLP.
Matt received his Juris Doctor degree from the University of Pennsylvania Law School and his Bachelor of Science degree in Psychology and Business Administration from the University of Pittsburgh. He is admitted to practice in Pennsylvania.
This person is not in any teams
This person is not in any offices
Aclaris Therapeutics
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options.